For research use only. Not for therapeutic Use.
GAC0003A4 (Cat No.: I027898) is a small-molecule compound being studied for its potential in treating cancer. It is designed to inhibit specific molecular targets involved in tumor progression, such as signaling pathways regulating cell growth, survival, and metastasis. The compound shows promise in preclinical studies for its ability to disrupt key proteins or enzymes in cancer cells. Researchers are investigating GAC0003A4’s mechanism of action, aiming to develop it as a novel therapeutic option for solid tumors and hematologic malignancies.
| CAS Number | 929492-71-7 |
| Synonyms | (3,5-dimethoxyphenyl)-[4-(2-methylphenyl)piperazin-1-yl]methanone |
| Molecular Formula | C20H24N2O3 |
| Purity | ≥95% |
| InChI | InChI=1S/C20H24N2O3/c1-15-6-4-5-7-19(15)21-8-10-22(11-9-21)20(23)16-12-17(24-2)14-18(13-16)25-3/h4-7,12-14H,8-11H2,1-3H3 |
| InChIKey | YOXCWYCROVRVBS-UHFFFAOYSA-N |
| SMILES | CC1=CC=CC=C1N2CCN(CC2)C(=O)C3=CC(=CC(=C3)OC)OC |
| Reference | [1]. Karaboga H, et al. Screening of Focused Compound Library Targeting Liver X Receptors in Pancreatic Cancer Identified Ligands with Inverse Agonist and Degrader Activity. ACS Chem Biol. 2020 Nov 20;15(11):2916-2928. |
| Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |
